Free Trial

Cara Therapeutics (CARA) SEC Filings & 10K Form

Cara Therapeutics logo
$0.30 0.00 (0.00%)
(As of 11/20/2024 ET)

Recent Cara Therapeutics SEC Filings

DateFilerForm TypeView
11/06/2024
3:51 PM
Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:21 PM
Cara Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
Form SC 13D
08/01/2024
3:15 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Cara Therapeutics (Subject)
Form SC 13G/A
06/12/2024
4:12 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:26 PM
Cara Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:28 PM
Boudreau Helen M (Reporting)
Cara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
3:07 PM
Cara Therapeutics (Filer)
Form ARS
04/22/2024
3:08 PM
Cara Therapeutics (Filer)
Form DEFA14A
04/12/2024
3:15 PM
Cara Therapeutics (Filer)
Cara Therapeutics (Filer)
Form PRE 14A
04/09/2024
3:21 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:22 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:16 PM
Cara Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2024
3:24 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:13 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:19 PM
Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:50 PM
Bain Capital Life Sciences Opportunities III, LP (Filed by)
Cara Therapeutics (Subject)
Form SC 13G/A
02/12/2024
4:10 PM
Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:13 PM
Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:15 PM
Cara Therapeutics (Issuer)
Maynard Ryan D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:16 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:32 PM
Cara Therapeutics (Issuer)
Maynard Ryan D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:34 PM
Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:59 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
2:26 PM
BlackRock Inc. (Filed by)
Cara Therapeutics (Subject)
Form SC 13G/A
01/22/2024
3:19 PM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
6:10 AM
Cara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CARA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners